000 | 01455 a2200433 4500 | ||
---|---|---|---|
005 | 20250518084150.0 | ||
264 | 0 | _c20210810 | |
008 | 202108s 0 0 eng d | ||
022 | _a1365-2710 | ||
024 | 7 |
_a10.1111/jcpt.13125 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKim, Dong Wook | |
245 | 0 | 0 |
_aThrombocytopenia during intravenous valproic acid therapy in the neurological intensive care unit. _h[electronic resource] |
260 |
_bJournal of clinical pharmacy and therapeutics _cOct 2020 |
||
300 |
_a1014-1020 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdministration, Intravenous |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnticonvulsants _xadministration & dosage |
650 | 0 | 4 | _aCritical Illness |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 | _aIntensive Care Units |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPlatelet Count |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aThrombocytopenia _xepidemiology |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aValproic Acid _xadministration & dosage |
700 | 1 | _aKim, Wonshik | |
700 | 1 | _aLee, Chang-Hoon | |
700 | 1 | _aChun, Young Il | |
773 | 0 |
_tJournal of clinical pharmacy and therapeutics _gvol. 45 _gno. 5 _gp. 1014-1020 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/jcpt.13125 _zAvailable from publisher's website |
999 |
_c30617075 _d30617075 |